(Q24810987)

5 July 2017

title

Modelling vaccination schedules for a cancer immunoprevention vaccine (English)

1 reference

5 July 2017

0 references

0 references

Santo Motta

1

1 reference

5 July 2017

Filippo Castiglione

series ordinal

2

1 reference

5 July 2017

Pierluigi Lollini

series ordinal

3

1 reference

5 July 2017

Francesco Pappalardo

series ordinal

4

1 reference

5 July 2017

language of work or name

English

0 references

publication date

7 October 2005

1 reference

5 July 2017

1 reference

5 July 2017

volume

1

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

5

1 reference

Cancer immunotherapy: moving beyond current vaccines

5 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

7 April 2017

Cancer immunoprevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

Interleukin-12 in anti-tumor immunity and immunotherapy.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

The immune system. First of two parts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

Immunoprevention of cancer: is the time ripe?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

Tumor heterogeneity and progression: conceptual foundations for modeling

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

A controlled trial of a human papillomavirus type 16 vaccine

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

An innate sense of danger

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287065

Modeling and simulation of cancer immunoprevention vaccine

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16305756

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16305756

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1745-7580-1-5

1 reference

Dimensions Publication ID

5 July 2017

0 references

1 reference

5 July 2017

1 reference